Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Homozygous 31 trinucleotide repeats in the SCA2 allele are pathogenic for cerebellar ataxia.

Tojima M, Murakami G, Hikawa R, Yamakado H, Yamashita H, Takahashi R, Matsui M.

Neurol Genet. 2018 Oct 16;4(6):e283. doi: 10.1212/NXG.0000000000000283. eCollection 2018 Dec. No abstract available.

2.

Ischemic Fasciitis of the Left Buttock in a 40-Year-Old Woman with Beta-Propeller Protein-Associated Neurodegeneration (BPAN).

Sakamoto A, Arai R, Okamoto T, Yamada Y, Yamakado H, Matsuda S.

Am J Case Rep. 2018 Oct 20;19:1249-1252. doi: 10.12659/AJCR.911300.

3.

Exploration of Carbon Allotropes with Four-membered Ring Structures on Quantum Chemical Potential Energy Surfaces.

Ohno K, Satoh H, Iwamoto T, Tokoyama H, Yamakado H.

J Comput Chem. 2019 Jan 5;40(1):14-28. doi: 10.1002/jcc.25556. Epub 2018 Oct 3. Review.

PMID:
30284308
4.

Ser46-Phosphorylated MARCKS Is a Marker of Neurite Degeneration at the Pre-aggregation Stage in PD/DLB Pathology.

Fujita K, Homma H, Kondo K, Ikuno M, Yamakado H, Tagawa K, Murayama S, Takahashi R, Okazawa H.

eNeuro. 2018 Sep 4;5(4). pii: ENEURO.0217-18.2018. doi: 10.1523/ENEURO.0217-18.2018. eCollection 2018 Jul-Aug.

5.

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.

Kim C, Spencer B, Rockenstein E, Yamakado H, Mante M, Adame A, Fields JA, Masliah D, Iba M, Lee HJ, Rissman RA, Lee SJ, Masliah E.

Mol Neurodegener. 2018 Aug 9;13(1):43. doi: 10.1186/s13024-018-0276-2.

6.

Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.

Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R.

Mol Neurodegener. 2018 May 11;13(1):21. doi: 10.1186/s13024-018-0257-5.

7.

Quantum chemical exploration of formaldehyde clusters (H2 CO)n (n = 2-4).

Ohno K, Kodaya Y, Yamakado H.

J Comput Chem. 2018 Jul 30;39(20):1498-1507. doi: 10.1002/jcc.25220. Epub 2018 Apr 1.

PMID:
29607516
8.

Amyotrophic Lateral Sclerosis after Receiving the Human Papilloma Virus Vaccine: A Case Report of a 15-year-old Girl.

Hikiami R, Yamakado H, Tatsumi S, Ayaki T, Hashi Y, Yamashita H, Sawamoto N, Tsuji T, Urushitani M, Takahashi R.

Intern Med. 2018 Jul 1;57(13):1917-1919. doi: 10.2169/internalmedicine.0285-17. Epub 2018 Feb 9.

9.

Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type.

Ihse E, Yamakado H, van Wijk XM, Lawrence R, Esko JD, Masliah E.

Sci Rep. 2017 Aug 21;7(1):9008. doi: 10.1038/s41598-017-08720-5.

10.

Altered awareness of action in Parkinson's disease: evaluations by explicit and implicit measures.

Saito N, Takahata K, Yamakado H, Sawamoto N, Saito S, Takahashi R, Murai T, Takahashi H.

Sci Rep. 2017 Aug 14;7(1):8019. doi: 10.1038/s41598-017-08482-0.

11.

Zonisamide inhibits monoamine oxidase and enhances motor performance and social activity.

Uemura MT, Asano T, Hikawa R, Yamakado H, Takahashi R.

Neurosci Res. 2017 Nov;124:25-32. doi: 10.1016/j.neures.2017.05.008. Epub 2017 Jun 15.

12.

Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains.

Kikuchi T, Morizane A, Doi D, Okita K, Nakagawa M, Yamakado H, Inoue H, Takahashi R, Takahashi J.

J Neurosci Res. 2017 Sep;95(9):1829-1837. doi: 10.1002/jnr.24014. Epub 2017 Feb 24.

13.

Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.

Kinoshita H, Yamakado H, Kitano T, Kitamura A, Yamashita H, Miyamoto M, Hitomi T, Okada T, Nakamoto Y, Sawamoto N, Takaori-Kondo A, Takahashi R.

J Neurol. 2016 Sep;263(9):1719-26. doi: 10.1007/s00415-016-8190-4. Epub 2016 Jun 10.

PMID:
27286845
14.

A case of variant biochemical phenotype of Niemann-Pick disease type C accompanying savant syndrome.

Hamatani M, Jingami N, Uemura K, Nakasone N, Kinoshita H, Yamakado H, Ninomiya H, Takahashi R.

Rinsho Shinkeigaku. 2016 Jun 22;56(6):424-9. doi: 10.5692/clinicalneurol.cn-000846. Epub 2016 May 14. Japanese.

PMID:
27181747
15.
16.

Theoretical studies on a carbonaceous molecular bearing: association thermodynamics and dual-mode rolling dynamics.

Isobe H, Nakamura K, Hitosugi S, Sato S, Tokoyama H, Yamakado H, Ohno K, Kono H.

Chem Sci. 2015 May 1;6(5):2746-2753. doi: 10.1039/c5sc00335k. Epub 2015 Feb 18.

17.

Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein.

Uemura N, Koike M, Ansai S, Kinoshita M, Ishikawa-Fujiwara T, Matsui H, Naruse K, Sakamoto N, Uchiyama Y, Todo T, Takeda S, Yamakado H, Takahashi R.

PLoS Genet. 2015 Apr 2;11(4):e1005065. doi: 10.1371/journal.pgen.1005065. eCollection 2015 Apr.

18.

Advance in PD research explored a new field on ubiquitin biology.

Yamakado H.

Mov Disord. 2014 Sep;29(10):1243. doi: 10.1002/mds.25977. Epub 2014 Aug 18. No abstract available.

PMID:
25137519
19.

[Two cases of acute onset of focal cortical reflex myoclonus following acute aseptic meningoencephalitis with positive anti-glutamate receptor autoantibody].

Tojima M, Hitomi T, Jingami N, Tanioka K, Yamakado H, Matsumoto R, Takahashi Y, Ikeda A, Takahashi R.

Rinsho Shinkeigaku. 2014;54(7):543-9. Japanese.

PMID:
25087554
20.

Exploring the pathogenetic mechanisms underlying Parkinson's disease in medaka fish.

Matsui H, Uemura N, Yamakado H, Takeda S, Takahashi R.

J Parkinsons Dis. 2014;4(2):301-10. doi: 10.3233/JPD-130289. Review.

PMID:
24366926
21.

The function of parkin: revisited.

Yamakado H, Takahashi R.

Mov Disord. 2013 Dec;28(14):1936. doi: 10.1002/mds.25711. Epub 2013 Nov 19. No abstract available.

PMID:
24249069
22.

Genetic correction will be a standard method for the patient-derived ips cell research?

Takahashi R, Yamakado H.

Mov Disord. 2013 Dec;28(14):1935. doi: 10.1002/mds.25710. Epub 2013 Nov 14. No abstract available.

PMID:
24243772
23.

Chicken DT40 cell line lacking DJ-1, the gene responsible for familial Parkinson's disease, displays mitochondrial dysfunction.

Minakawa EN, Yamakado H, Tanaka A, Uemura K, Takeda S, Takahashi R.

Neurosci Res. 2013 Dec;77(4):228-33. doi: 10.1016/j.neures.2013.09.006. Epub 2013 Sep 21.

PMID:
24064392
24.

Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in mice.

Ageta-Ishihara N, Yamakado H, Morita T, Hattori S, Takao K, Miyakawa T, Takahashi R, Kinoshita M.

Mol Brain. 2013 Aug 11;6:35. doi: 10.1186/1756-6606-6-35.

25.

PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates.

Matsui H, Gavinio R, Asano T, Uemura N, Ito H, Taniguchi Y, Kobayashi Y, Maki T, Shen J, Takeda S, Uemura K, Yamakado H, Takahashi R.

Hum Mol Genet. 2013 Jun 15;22(12):2423-34. doi: 10.1093/hmg/ddt095. Epub 2013 Feb 27.

PMID:
23449626
26.

A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Schönig K, Zimmermann F, Bauer C, Casadei N, Giel C, Calaminus C, Pichler BJ, Jensen PH, Müller CP, Amato D, Kornhuber J, Teismann P, Yamakado H, Takahashi R, Winkler J, Masliah E, Riess O.

Brain. 2013 Feb;136(Pt 2):412-32. doi: 10.1093/brain/aws358.

27.

α-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotion.

Yamakado H, Moriwaki Y, Yamasaki N, Miyakawa T, Kurisu J, Uemura K, Inoue H, Takahashi M, Takahashi R.

Neurosci Res. 2012 Jun;73(2):173-7. doi: 10.1016/j.neures.2012.03.010. Epub 2012 Mar 28.

PMID:
22475625
28.

[Unverricht-Lundborg disease manifesting tremulous myoclonus with rare convulsive seizures: a case report].

Kondo T, Yamakado H, Kawamata J, Tomimoto H, Hitomi T, Takahashi R, Ikeda A.

Rinsho Shinkeigaku. 2009 Jan;49(1):43-7. Japanese.

PMID:
19227896
29.

Cocaine and phenylephrine eye drop test for Parkinson disease.

Sawada H, Yamakawa K, Yamakado H, Hosokawa R, Ohba M, Miyamoto K, Kawamura T, Shimohama S.

JAMA. 2005 Feb 23;293(8):932-4. No abstract available.

PMID:
15728162
30.

Successful allogeneic blood stem cell transplantation for aplastic anemia in a patient with renal insufficiency requiring dialysis.

Hamaki T, Katori H, Kami M, Yamato T, Yamakado H, Itoh T, Kusumi E, Igarashi M, Ueyama J, Kanda Y, Miyakoshi S, Mineishi S, Morinaga S, Mukai M, Hayashi M, Takaue Y, Hara S, Mutou Y.

Bone Marrow Transplant. 2002 Aug;30(3):195-8.

31.

[Community psychiatric hospital attitude regarding access to health records].

Yamakado H.

Seishin Shinkeigaku Zasshi. 2001;103(1):9-11. Japanese. No abstract available.

PMID:
11383014
32.

Metal-semiconductor transition and structural change in (BEDT-TTF)3(ClO4)2.

Enoki T, Tsujikawa K, Suzuki K, Uchida A, Ohashi Y, Yamakado H, Yakushi K, Saito G.

Phys Rev B Condens Matter. 1994 Dec 1;50(22):16287-16294. No abstract available.

PMID:
9976014
33.

[Level of acquirement of clinical knowledge and skills among second-year residents].

Fukui T, Sugita S, Yamaoka K, Niino N, Yamakado H, Nishizaki H, Ogata T, Segami K, Yano E.

Nihon Koshu Eisei Zasshi. 1990 Sep;37(9):793-802. Japanese. No abstract available.

PMID:
2132397

Supplemental Content

Loading ...
Support Center